Changing the chronic kidney disease landscape

The economic benefits of early detection and treatment

Kidney Health Australia commissioned Deloitte Access Economics to estimate the socioeconomic cost of chronic kidney disease (CKD) and the return that can be realised through investment in early detection and best practice treatment of CKD.
Find out more